Audrey Hubert
Overview
Explore the profile of Audrey Hubert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hubert A, Achour D, Grare C, Zarcone G, Muntaner M, Hamroun A, et al.
Environ Int
. 2023 Apr;
174:107913.
PMID: 37037173
Introduction: MicroRNAs are epigenetic regulatory factors capable of silencing the expression of target genes and might mediate the effects of air pollution on health. The objective of the present population-based...
2.
Beniey M, Hubert A, Haque T, Cotte A, Bechir N, Zhang X, et al.
Br J Cancer
. 2023 Mar;
128(10):1964-1975.
PMID: 36941406
Background: Patients with triple-negative breast cancer (TNBC) develop early recurrence. While PARP inhibitors (PARPi) have demonstrated potential in BRCA1/2-mutant (BRCA) TNBC, durable responses will likely be achieved if PARPi are...
3.
Boucher J, Rousseau A, Boucher C, Subra C, Bazie W, Hubert A, et al.
Cells
. 2023 Feb;
12(3).
PMID: 36766808
The hallmark of HIV-1 infection is the rapid dysregulation of immune functions. Recent investigations for biomarkers of such dysregulation in people living with HIV (PLWH) reveal a strong correlation between...
4.
Yordanova M, Hubert A, Hassan S
Pharmaceuticals (Basel)
. 2021 Dec;
14(12).
PMID: 34959671
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and is known to be associated with a poor prognosis and limited therapeutic options. Poly (ADP-ribose) polymerase inhibitors...
5.
Vaillancourt M, Hubert A, Subra C, Boucher J, Bazie W, Vitry J, et al.
Pathogens
. 2021 Apr;
10(5).
PMID: 33925397
Extracellular vesicles (EVs) and their contents (proteins, lipids, messenger RNA, microRNA, and DNA) are viewed as intercellular signals, cell-transforming agents, and shelters for viruses that allow both diagnostic and therapeutic...
6.
Filleron A, Tran T, Hubert A, Letierce A, Churlaud G, Kone-Paut I, et al.
Rheumatology (Oxford)
. 2021 Mar;
61(1):422-429.
PMID: 33734346
Objectives: Behçet disease (BD) is a chronic systemic inflammatory disorder of unknown aetiology. The aim of this study was to determine the orientation of T cell subpopulations in paediatric BD...
7.
Fovet C, Stimmer L, Contreras V, Horellou P, Hubert A, Seddiki N, et al.
EBioMedicine
. 2019 Sep;
47:492-505.
PMID: 31492559
Background: Autoimmune demyelinating diseases (ADD) are a major cause of neurological disability due to autoreactive cellular and humoral immune responses against brain antigens. A cure for chronic ADD could be...
8.
Hubert A, Seddiki N
Hum Vaccin Immunother
. 2018 Jan;
14(6):1432-1437.
PMID: 29381418
The field of immunotherapeutics is living an exceptional time as new antibodies that take brakes off T-cells and unleash them on tumours are being approved by the US-Food and Drug...
9.
Brezar V, Hani L, Surenaud M, Hubert A, Lacabaratz C, Lelievre J, et al.
PLoS Pathog
. 2017 Jul;
13(7):e1006489.
PMID: 28708863
The potential benefit in using IL-2 in immunotherapy for cancer and autoimmunity has been linked to the modulation of immune responses, which partly relies on a direct effect on Tregs...
10.
Hubert A, Subra C, Jenabian M, Tremblay Labrecque P, Tremblay C, Laffont B, et al.
J Acquir Immune Defic Syndr
. 2015 Jul;
70(3):219-27.
PMID: 26181817
Background: Because of factors only partly understood, the generalized elevated immune activation and inflammation characterizing HIV-1-infected patients are corrected incompletely with antiretroviral therapy (ART). Extracellular vesicles (EVs) including exosomes and...